DK1704148T3 - Nye kondenserede pyrrolocarbazoler - Google Patents

Nye kondenserede pyrrolocarbazoler

Info

Publication number: DK1704148T3
Authority: DK; Denmark
Prior art keywords: new condensed; condensed pyrrolocarbazoles; pyrrolocarbazoles; new; condensed
Prior art date: 2003-12-23

Application number

DK04815262.3T

Other languages

English (en)

Inventor

Theodore L Underiner

Allison L Zulli

Nadine C Becknell

James L Diebold

Diane E Gingrich

Robert L Hudkins

Dandu R Reddy

Ming Tao

Original Assignee

Cephalon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2004-12-23

Publication date

2011-06-14

2004-12-23 Application filed by Cephalon Inc filed Critical Cephalon Inc

2011-06-14 Application granted granted Critical

2011-06-14 Publication of DK1704148T3 publication Critical patent/DK1704148T3/da

Links

QNMMYUBZGLXCCK-UHFFFAOYSA-N pyrrolo[3,2-a]carbazole Chemical class N1=C2C=CC=CC2=C2C1=C1C=CN=C1C=C2 QNMMYUBZGLXCCK-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Hematology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)

DK04815262.3T 2003-12-23 2004-12-23 Nye kondenserede pyrrolocarbazoler DK1704148T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US53218203P	2003-12-23	2003-12-23
US11/017,947 US7169802B2 (en)	2003-12-23	2004-12-22	Fused pyrrolocarbazoles
PCT/US2004/043160 WO2005063763A1 (en)	2003-12-23	2004-12-23	Novel fused pyrrolocarbazoles

Publications (1)

Publication Number	Publication Date
DK1704148T3 true DK1704148T3 (da)	2011-06-14

Family

ID=34703676

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04815262.3T DK1704148T3 (da)	2003-12-23	2004-12-23	Nye kondenserede pyrrolocarbazoler

Country Status (29)

Country	Link
US (4)	US7169802B2 (da)
EP (1)	EP1704148B1 (da)
JP (1)	JP5006046B2 (da)
KR (2)	KR20120066057A (da)
CN (1)	CN1918162B (da)
AR (1)	AR047168A1 (da)
AT (1)	ATE500256T1 (da)
AU (1)	AU2004309394B2 (da)
BR (1)	BRPI0418113B8 (da)
CA (1)	CA2549627C (da)
CR (1)	CR8519A (da)
CY (1)	CY1111524T1 (da)
DE (1)	DE602004031672D1 (da)
DK (1)	DK1704148T3 (da)
EA (1)	EA012295B1 (da)
HR (1)	HRP20110373T1 (da)
IL (1)	IL176384A (da)
IS (1)	IS8519A (da)
MA (1)	MA28298A1 (da)
MY (2)	MY143373A (da)
NO (2)	NO336893B1 (da)
NZ (1)	NZ548099A (da)
PL (1)	PL1704148T3 (da)
PT (1)	PT1704148E (da)
RS (1)	RS51886B (da)
SG (1)	SG149045A1 (da)
SI (1)	SI1704148T1 (da)
TW (1)	TWI355385B (da)
WO (1)	WO2005063763A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060276497A1 (en) *	2000-05-09	2006-12-07	Cephalon, Inc.	Novel multicyclic compounds and the use thereof
US7241779B2 (en) *	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles
SE0401790D0 (sv) *	2004-07-07	2004-07-07	Forskarpatent I Syd Ab	Tamoxifen response in pre- and postmenopausal breast cancer patients
EP2064178A4 (en) *	2006-09-08	2011-10-05	Merck Canada Inc	PRODRUGS OF INHIBITORS OF CATHEPSIN S
US20080125377A1 (en) *	2006-11-28	2008-05-29	Bartels Stephen P	Delivery system for antiangiogenic and antiinflammatory pharmaceuticals and method of use
EP2167075A4 (en) *	2007-06-08	2012-07-11	Univ Massachusetts	MIXED LINEAGE KINASES AND METABOLISM DISORDER
TWI580694B (zh)	2007-11-30	2017-05-01	建南德克公司	抗-ｖｅｇｆ抗體
UA107652C2 (en) *	2008-10-06	2015-02-10	Incuron Llc	Carbazole compounds and therapeutic uses of the compounds
WO2010048446A2 (en)	2008-10-22	2010-04-29	Genentech, Inc.	Modulation of axon degeneration
CN102216306B (zh) *	2008-11-19	2014-12-24	赛福伦公司	吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式
EP2192121A1 (en) *	2008-11-27	2010-06-02	Cephalon France	Regioselective reduction of fused pyrrolocarbazoles-5,7-diones
TWI461410B (zh) *	2008-12-30	2014-11-21	Arqule Inc	經取代之５，６－二氫－６－苯基苯並〔f〕異喹啉－２－胺化合物類
US8263610B2 (en) *	2008-12-30	2012-09-11	Arqule, Inc.	Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds
CA2778483A1 (en) *	2009-10-22	2011-04-28	Genentech, Inc.	Modulation of axon degeneration
US20110189174A1 (en) *	2010-02-01	2011-08-04	Afshin Shafiee	Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
KR101815332B1 (ko) *	2010-05-18	2018-01-04	세파론, 인코포레이티드	융합 피롤로카르바졸 유도체의 정제 방법
CN103664797A (zh) *	2012-09-25	2014-03-26	杨子娇	一类治疗房角狭窄的化合物及其用途
CN104370880A (zh) *	2013-01-24	2015-02-25	韩冰	一类蛋白酶抑制剂及其制备方法和用途
EP2954331B1 (en)	2013-02-11	2018-03-28	Incuron LLC	Use of facilitates chromatin transcription complex (fact) in cancer
US9884853B2 (en) *	2013-09-26	2018-02-06	Chdi Foundation, Inc.	Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CN106572992A (zh)	2014-04-06	2017-04-19	英丘伦有限责任公司	用curaxins进行组合治疗

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ245203A (en)	1991-11-29	1997-07-27	Banyu Pharma Co Ltd	5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5475110A (en)	1994-10-14	1995-12-12	Cephalon, Inc.	Fused Pyrrolocarbazoles
US5594009A (en)	1994-10-14	1997-01-14	Cephalon, Inc.	Fused pyrrolocarbazoles
US5591855A (en)	1994-10-14	1997-01-07	Cephalon, Inc.	Fused pyrrolocarbazoles
US5705511A (en) *	1994-10-14	1998-01-06	Cephalon, Inc.	Fused pyrrolocarbazoles
US5616724A (en)	1996-02-21	1997-04-01	Cephalon, Inc.	Fused pyrrolo[2,3-c]carbazole-6-ones
HUP9903931A3 (en)	1996-08-22	2000-09-28	Bristol Myers Squibb Co Wallin	Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
US6841567B1 (en) *	1999-02-12	2005-01-11	Cephalon, Inc.	Cyclic substituted fused pyrrolocarbazoles and isoindolones
US6399780B1 (en)	1999-08-20	2002-06-04	Cephalon, Inc.	Isomeric fused pyrrolocarbazoles and isoindolones
US6630500B2 (en)	2000-08-25	2003-10-07	Cephalon, Inc.	Selected fused pyrrolocarbazoles
TR200401316T4 (tr)	2000-09-29	2004-07-21	Eli Lilly And Company	Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
US6653290B2 (en)	2000-10-06	2003-11-25	Bristol-Myers Squibb Company	Tumor proliferation inhibitors
US6610727B2 (en)	2000-10-06	2003-08-26	Bristol-Myers Squibb Company	Anhydro sugar derivatives of indolocarbazoles
US7018999B2 (en)	2001-05-16	2006-03-28	Cephalon, Inc.	Methods for the treatment and prevention of pain
US7241779B2 (en) *	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles

2004
- 2004-12-22 US US11/017,947 patent/US7169802B2/en not_active Expired - Lifetime
- 2004-12-23 JP JP2006547322A patent/JP5006046B2/ja not_active Expired - Lifetime
- 2004-12-23 SI SI200431670T patent/SI1704148T1/sl unknown
- 2004-12-23 EP EP04815262A patent/EP1704148B1/en not_active Expired - Lifetime
- 2004-12-23 KR KR1020127011232A patent/KR20120066057A/ko not_active Ceased
- 2004-12-23 WO PCT/US2004/043160 patent/WO2005063763A1/en not_active Ceased
- 2004-12-23 MY MYPI20045332A patent/MY143373A/en unknown
- 2004-12-23 DE DE602004031672T patent/DE602004031672D1/de not_active Expired - Lifetime
- 2004-12-23 PT PT04815262T patent/PT1704148E/pt unknown
- 2004-12-23 TW TW093140222A patent/TWI355385B/zh not_active IP Right Cessation
- 2004-12-23 NZ NZ548099A patent/NZ548099A/en not_active IP Right Cessation
- 2004-12-23 RS RS20110203A patent/RS51886B/sr unknown
- 2004-12-23 DK DK04815262.3T patent/DK1704148T3/da active
- 2004-12-23 BR BRPI0418113A patent/BRPI0418113B8/pt active IP Right Grant
- 2004-12-23 EA EA200601217A patent/EA012295B1/ru not_active IP Right Cessation
- 2004-12-23 HR HR20110373T patent/HRP20110373T1/hr unknown
- 2004-12-23 KR KR1020067014792A patent/KR101179372B1/ko not_active Expired - Fee Related
- 2004-12-23 AT AT04815262T patent/ATE500256T1/de active
- 2004-12-23 AU AU2004309394A patent/AU2004309394B2/en not_active Expired
- 2004-12-23 SG SG200809413-8A patent/SG149045A1/en unknown
- 2004-12-23 MY MYPI20093362A patent/MY158159A/en unknown
- 2004-12-23 CN CN200480041770.5A patent/CN1918162B/zh not_active Expired - Lifetime
- 2004-12-23 CA CA2549627A patent/CA2549627C/en not_active Expired - Lifetime
- 2004-12-23 PL PL04815262T patent/PL1704148T3/pl unknown
- 2004-12-27 AR ARP040104890A patent/AR047168A1/es not_active Application Discontinuation
2006
- 2006-06-18 IL IL176384A patent/IL176384A/en active IP Right Grant
- 2006-06-22 IS IS8519A patent/IS8519A/xx unknown
- 2006-06-29 US US11/477,639 patent/US7671064B2/en not_active Expired - Lifetime
- 2006-07-10 NO NO20063196A patent/NO336893B1/no not_active IP Right Cessation
- 2006-07-17 MA MA29192A patent/MA28298A1/fr unknown
- 2006-07-19 CR CR8519A patent/CR8519A/es unknown
2010
- 2010-02-18 US US12/708,306 patent/US8044064B2/en not_active Expired - Lifetime
2011
- 2011-06-01 CY CY20111100533T patent/CY1111524T1/el unknown
- 2011-09-16 US US13/234,501 patent/US8383813B2/en not_active Expired - Lifetime
2015
- 2015-09-23 NO NO20151245A patent/NO20151245A1/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EA200601217A1 (ru)	2006-12-29
CY1111524T1 (el)	2015-08-05
US20100152196A1 (en)	2010-06-17
CN1918162A (zh)	2007-02-21
AR047168A1 (es)	2006-01-11
US20050143442A1 (en)	2005-06-30
JP2007516293A (ja)	2007-06-21
IL176384A0 (en)	2006-10-05
US7671064B2 (en)	2010-03-02
EP1704148A1 (en)	2006-09-27
US20120004253A1 (en)	2012-01-05
TW200530243A (en)	2005-09-16
BRPI0418113B1 (pt)	2020-04-14
NO20063196L (no)	2006-09-20
MA28298A1 (fr)	2006-11-01
ATE500256T1 (de)	2011-03-15
RS51886B (sr)	2012-02-29
CA2549627C (en)	2012-12-11
KR101179372B1 (ko)	2012-09-03
MY158159A (en)	2016-09-15
US20060247294A1 (en)	2006-11-02
AU2004309394B2 (en)	2011-04-28
US8383813B2 (en)	2013-02-26
JP5006046B2 (ja)	2012-08-22
IL176384A (en)	2015-05-31
CA2549627A1 (en)	2005-07-14
NZ548099A (en)	2010-05-28
BRPI0418113B8 (pt)	2021-05-25
DE602004031672D1 (de)	2011-04-14
KR20120066057A (ko)	2012-06-21
IS8519A (is)	2006-06-22
HRP20110373T1 (hr)	2011-06-30
NO20151245A1 (no)	2015-09-23
HK1096096A1 (en)	2007-05-25
PT1704148E (pt)	2011-05-25
BRPI0418113A (pt)	2007-04-17
NO336893B1 (no)	2015-11-23
SI1704148T1 (sl)	2011-06-30
PL1704148T3 (pl)	2011-07-29
AU2004309394A1 (en)	2005-07-14
MY143373A (en)	2011-04-29
CR8519A (es)	2007-06-06
TWI355385B (en)	2012-01-01
US8044064B2 (en)	2011-10-25
WO2005063763A1 (en)	2005-07-14
EA012295B1 (ru)	2009-08-28
SG149045A1 (en)	2009-01-29
KR20060127069A (ko)	2006-12-11
CN1918162B (zh)	2014-05-14
US7169802B2 (en)	2007-01-30
EP1704148B1 (en)	2011-03-02

Publication	Publication Date	Title
NO20055219D0 (no)	2005-11-04	Nye forbindelser
NO20054005D0 (no)	2005-08-29	Nye arylpiperazinylforbindelser
NO20054224D0 (no)	2005-09-12	Nye 2-pyridinkarboksamidderivater
NO20044588L (no)	2004-10-25	Nye forbindelser
NO20044432L (no)	2004-10-19	Nye forbindelser
DE50300325D1 (de)	2005-03-31	Vaginalpflegezusammensetzung
DE602004030244D1 (de)	2011-01-05	Itoren
DE602004031657D1 (de)	2011-04-14	Einführstützsystem
DE60311768D1 (de)	2007-03-29	Axiallüftereinheit
DK1704148T3 (da)	2011-06-14	Nye kondenserede pyrrolocarbazoler
DE602004009385D1 (de)	2007-11-22	Spurhaltevorrichtung
DK1610609T3 (da)	2014-09-01	Fluid-opvarmer
EP1603979A4 (en)	2006-04-05	ANTI-ALLOY PAINT COMPOSITION
DE60307903D1 (de)	2006-10-05	Impedanzanpassungskoppler
DE502004008321D1 (de)	2008-12-04	Bandaufwickelverfahren
DE602004021612D1 (de)	2009-07-30	Chtungsmassen
DE60331697D1 (de)	2010-04-22	Verzögerungszeitdiskriminator
DE50312763D1 (de)	2010-07-15	Schliessleiste
DE502004009786D1 (de)	2009-09-03	Rdnung
DE502004005544D1 (de)	2008-01-03	Mikrodosiereinrichtung
NO20030752D0 (no)	2003-02-17	Bölgedempningsanordning
ATE444953T1 (de)	2009-10-15	Substituierte spirobenzazepine
DE60330070D1 (de)	2009-12-24	Tracking-einrichtung
NO20044098L (no)	2004-10-04	Nye forbindelser
DE502004005162D1 (de)	2007-11-15	Leistungsregelvorricthung